• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Healthy.io Nabs $60M for FDA-cleared Smartphone-Based Urinalysis for Chronic Kidney Disease

by Jasmine Pennic 09/12/2019 Leave a Comment

Healthy.io Nabs $60M for FDA-cleared Smartphone-Based Urinalysis for Chronic Kidney Disease

– Healthy.io raises $60M led by Corner Ventures for its FDA 510(k) cleared smartphone-based ACR test to be used in the aid of diagnosing chronic kidney disease (CKD).


– The funding round will be used to accelerate Healthy.io’s global expansion and product development.


– Healthy.io’s solution allows immediate electronic medical record (EMR) connectivity through the automated smartphone scan.


 Healthy.io, the fast-growing Israeli digital health company that has turned the smartphone into a clinical-grade medical device has raised $60 million in Series C funding led by Corner Ventures with participation by Joy Capital and all previous investors: Ansonia Holdings, Aleph, and Samsung NEXT. In addition, the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its smartphone-based ACR test to be used in the aid of diagnosing chronic kidney disease (CKD), which affects over 35 million Americans. 

Albumin-to-Creatinine Ratio (ACR) Urine Testing

Albuminuria is increased excretion of urinary albumin and a marker of kidney damage. Normal individuals excrete very small amounts of protein in the urine. Albumin is the most common type of protein in the urine. All patients with CKD should be screened for albuminuria. Persistent increased protein in the urine (two positive tests over 3 or more months) is the principal marker of kidney damage, acting as an early and sensitive marker in many types of kidney disease.

Detecting albuminuria

A routine dipstick is not sensitive enough to detect small amounts of urine protein. Therefore, it is recommended that screening in adults with CKD or at risk for CKD be done by testing for albuminuria.

Albumin-to-creatinine ratio (ACR) is the first method of preference to detect elevated protein. The recommended method to evaluate albuminuria is to measure urinary ACR in a spot urine sample. ACR is calculated by dividing albumin concentration in milligrams by creatinine concentration in grams. Healthy.io has developed a system that allows patients to use their smartphone for a quick and easy Protein urine test at home (ACR). Testing is as simple as taking a selfie.

FDA Clearance for Smart-Based ACR Test for Chronic Kidney Disease Diagnosis

The FDA clearance designates Healthy.io’s smartphone-based ACR test as substantially equivalent to lab-based testing and authorizes the use of the test by healthcare professionals at any point of care, such as a pharmacy, urgent care center, or health clinic and send results directly to patients’ EHR/EMR. This is Healthy.io’s second FDA clearance, as last year Healthy.io received clearance for its at-home, smartphone-based 10 parameter urinalysis test kit, called Dip.io, that can be used in testing for UTIs or in prenatal care.  

Healthy.io offers the only smartphone-based urinalysis cleared by FDA and European regulators as equivalent to lab-based testing, is fully in-market in the UK, in hundreds of Boots drugstores and with the NHS, and Israel, through the three largest HMOs, and has published research with Johns Hopkins University and Geisinger Health, and the National Kidney Foundation in the U.S.

Expanding Product Development

With the new funding, Healthy.io will continue its product development. The company recently announced a partnership with Boots UK, placing its Dip UTI test kits in hundreds of pharmacies, allowing women to test and treat common UTIs, and announced a new pharmacy evaluation with the National Health Service (NHS) in England.

Why It Matters

“The smartphone has the potential to be the great equalizer of healthcare,” said Yonatan Adiri, founder and CEO of Healthy.io. “To unlock this potential, companies must adhere to the highest clinical standards. Our second FDA clearance and additional funding allows us to expand access to critical tests and care beyond our first 100,000 patients in Europe and Israel, making it a reality for millions of Americans suffering from diabetes and hypertension, who are at risk for chronic kidney disease.”

RELATED:   Death by Ransomware: Poor Healthcare Cybersecurity

Tagged With: diabetes, digital health, electronic medical record, EMR, FDA, FDA Clearance, FDA Cleared Devices, Healthy.io, Hypertension, Kidney Disease, Medical Device, NHS, Pharmacy, point of care, risk, Samsung, urgent care

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Incredible Health Raises $15M to Transform The Way Nurses Get Hired
Cerner Unveils 5 Finalists for code App Challenge to Advance Consumers’ Access to EHRs »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • CVS Health Launches Senior Medical Alert System, Symphony

    CVS Health Launches Senior Medical Alert System, Symphony

    ... more
  • Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health

    Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

    ... more
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup

    MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process

    ... more
  • Heritage Group

    Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021 Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |